- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Piramal Pharma announced a board meeting approving financial results for the quarter and nine months. The company reported a consolidated net loss of Rs. 136.19 Cr for the quarter. A key update: its subsidiary plans to acquire Kenalog® for an upfront USD 35M & contingent USD 65M.